Clinical Trials · NCT00197860
Dendritic Cell Based Therapy of Renal Cell Carcinoma
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Inge Marie Svane
- Enrollment
- 40
- Start date
- Sep 2004
- Locations
- 1 site, Denmark
- Primary endpoint
- Primary aim of the study is to evaluate tolerability and safety of the treatment.